In addition to the MYC–G9A interaction, many cross-talks between cell reprogramming factors and chromatin remodelers were identified in breast cancer [50,73,75,76,77]; however, there might be many additional such networks that require further investigation. Here, EHMT2 is linked to breast cancer.